report-image

Global Medication Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 11/23/2022
  • NO OF PAGES
  • 236
  • CATEGORY
  • Healthcare & Life Sciences
The competitive landscape analysis of Medication Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.

Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Medication Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.

Market Segmentations:
Global Medication Market: Top Key Players
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda

Global Medication Market: By Types
Brand Drugs
Generic Drug

Global Medication Market: By Applications
Hospital
Clinic
Other

Global Medication Market: Regions/Countries
North America
Europe
China
Japan
Southeast Asia
India
Central & South America



Global Medication Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.

Reasons to Purchase Medication Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Medication Revenue
1.4 Market Analysis by Type
1.4.1 Global Medication Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Brand Drugs
1.4.3 Generic Drug
1.5 Market by Application
1.5.1 Global Medication Market Share by Application: 2022 VS 2030
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Medication Market Perspective (2016-2030)
2.2 Medication Growth Trends by Regions
2.2.1 Medication Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Medication Historic Market Share by Regions (2016-2021)
2.2.3 Medication Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Medication Market Growth Strategy
2.3.6 Primary Interviews with Key Medication Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Medication Players by Market Size
3.1.1 Global Top Medication Players by Revenue (2016-2021)
3.1.2 Global Medication Revenue Market Share by Players (2016-2021)
3.1.3 Global Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Medication Market Concentration Ratio
3.2.1 Global Medication Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2021
3.3 Medication Key Players Head office and Area Served
3.4 Key Players Medication Product Solution and Service
3.5 Date of Enter into Medication Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2030)
4.1 Global Medication Historic Market Size by Type (2016-2021)
4.2 Global Medication Forecasted Market Size by Type (2022-2030)

5 Medication Breakdown Data by Application (2016-2030)
5.1 Global Medication Market Size by Application (2016-2021)
5.2 Global Medication Forecasted Market Size by Application (2022-2030)

6 North America
6.1 North America Medication Market Size (2016-2021)
6.2 Medication Key Players in North America (2016-2021)
6.3 North America Medication Market Size by Type (2016-2021)
6.4 North America Medication Market Size by Application (2016-2021)

7 Europe
7.1 Europe Medication Market Size (2016-2021)
7.2 Medication Key Players in Europe (2016-2021)
7.3 Europe Medication Market Size by Type (2016-2021)
7.4 Europe Medication Market Size by Application (2016-2021)

8 China
8.1 China Medication Market Size (2016-2021)
8.2 Medication Key Players in China (2016-2021)
8.3 China Medication Market Size by Type (2016-2021)
8.4 China Medication Market Size by Application (2016-2021)

9 Japan
9.1 Japan Medication Market Size (2016-2021)
9.2 Medication Key Players in Japan (2016-2021)
9.3 Japan Medication Market Size by Type (2016-2021)
9.4 Japan Medication Market Size by Application (2016-2021)

10 Southeast Asia
10.1 Southeast Asia Medication Market Size (2016-2021)
10.2 Medication Key Players in Southeast Asia (2016-2021)
10.3 Southeast Asia Medication Market Size by Type (2016-2021)
10.4 Southeast Asia Medication Market Size by Application (2016-2021)

11 India
11.1 India Medication Market Size (2016-2021)
11.2 Medication Key Players in India (2016-2021)
11.3 India Medication Market Size by Type (2016-2021)
11.4 India Medication Market Size by Application (2016-2021)

12 Central & South America
12.1 Central & South America Medication Market Size (2016-2021)
12.2 Medication Key Players in Central & South America (2016-2021)
12.3 Central & South America Medication Market Size by Type (2016-2021)
12.4 Central & South America Medication Market Size by Application (2016-2021)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Medication Introduction
13.1.4 Pfizer Revenue in Medication Business (2016-2021)
13.1.5 Pfizer Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview and Its Total Revenue
13.2.3 Roche Medication Introduction
13.2.4 Roche Revenue in Medication Business (2016-2021)
13.2.5 Roche Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Medication Introduction
13.3.4 Sanofi Revenue in Medication Business (2016-2021)
13.3.5 Sanofi Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
13.4.3 Johnson & Johnson Medication Introduction
13.4.4 Johnson & Johnson Revenue in Medication Business (2016-2021)
13.4.5 Johnson & Johnson Recent Development
13.5 Merck & Co. (MSD)
13.5.1 Merck & Co. (MSD) Company Details
13.5.2 Merck & Co. (MSD) Business Overview and Its Total Revenue
13.5.3 Merck & Co. (MSD) Medication Introduction
13.5.4 Merck & Co. (MSD) Revenue in Medication Business (2016-2021)
13.5.5 Merck & Co. (MSD) Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Medication Introduction
13.6.4 Novartis Revenue in Medication Business (2016-2021)
13.6.5 Novartis Recent Development
13.7 AbbVie
13.7.1 AbbVie Company Details
13.7.2 AbbVie Business Overview and Its Total Revenue
13.7.3 AbbVie Medication Introduction
13.7.4 AbbVie Revenue in Medication Business (2016-2021)
13.7.5 AbbVie Recent Development
13.8 Gilead Sciences
13.8.1 Gilead Sciences Company Details
13.8.2 Gilead Sciences Business Overview and Its Total Revenue
13.8.3 Gilead Sciences Medication Introduction
13.8.4 Gilead Sciences Revenue in Medication Business (2016-2021)
13.8.5 Gilead Sciences Recent Development
13.9 GlaxoSmithKline (GSK)
13.9.1 GlaxoSmithKline (GSK) Company Details
13.9.2 GlaxoSmithKline (GSK) Business Overview and Its Total Revenue
13.9.3 GlaxoSmithKline (GSK) Medication Introduction
13.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2016-2021)
13.9.5 GlaxoSmithKline (GSK) Recent Development
13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview and Its Total Revenue
13.10.3 Amgen Medication Introduction
13.10.4 Amgen Revenue in Medication Business (2016-2021)
13.10.5 Amgen Recent Development
13.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview and Its Total Revenue
10.11.3 AstraZeneca Medication Introduction
10.11.4 AstraZeneca Revenue in Medication Business (2016-2021)
10.11.5 AstraZeneca Recent Development
13.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Company Details
10.12.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
10.12.3 Bristol-Myers Squibb Medication Introduction
10.12.4 Bristol-Myers Squibb Revenue in Medication Business (2016-2021)
10.12.5 Bristol-Myers Squibb Recent Development
13.13 Eli Lilly
10.13.1 Eli Lilly Company Details
10.13.2 Eli Lilly Business Overview and Its Total Revenue
10.13.3 Eli Lilly Medication Introduction
10.13.4 Eli Lilly Revenue in Medication Business (2016-2021)
10.13.5 Eli Lilly Recent Development
13.14 Teva
10.14.1 Teva Company Details
10.14.2 Teva Business Overview and Its Total Revenue
10.14.3 Teva Medication Introduction
10.14.4 Teva Revenue in Medication Business (2016-2021)
10.14.5 Teva Recent Development
13.15 Bayer
10.15.1 Bayer Company Details
10.15.2 Bayer Business Overview and Its Total Revenue
10.15.3 Bayer Medication Introduction
10.15.4 Bayer Revenue in Medication Business (2016-2021)
10.15.5 Bayer Recent Development
13.16 Novo Nordisk
10.16.1 Novo Nordisk Company Details
10.16.2 Novo Nordisk Business Overview and Its Total Revenue
10.16.3 Novo Nordisk Medication Introduction
10.16.4 Novo Nordisk Revenue in Medication Business (2016-2021)
10.16.5 Novo Nordisk Recent Development
13.17 Allergan
10.17.1 Allergan Company Details
10.17.2 Allergan Business Overview and Its Total Revenue
10.17.3 Allergan Medication Introduction
10.17.4 Allergan Revenue in Medication Business (2016-2021)
10.17.5 Allergan Recent Development
13.18 Takeda
10.18.1 Takeda Company Details
10.18.2 Takeda Business Overview and Its Total Revenue
10.18.3 Takeda Medication Introduction
10.18.4 Takeda Revenue in Medication Business (2016-2021)
10.18.5 Takeda Recent Development
13.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Company Details
10.19.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.19.3 Boehringer Ingelheim Medication Introduction
10.19.4 Boehringer Ingelheim Revenue in Medication Business (2016-2021)
10.19.5 Boehringer Ingelheim Recent Development
13.20 Takeda
10.20.1 Takeda Company Details
10.20.2 Takeda Business Overview and Its Total Revenue
10.20.3 Takeda Medication Introduction
10.20.4 Takeda Revenue in Medication Business (2016-2021)
10.20.5 Takeda Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

Sample Request Customized Requirement Speak to Analyst Check Discount
CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

Buy Now
  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

Buy Now
  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

Buy Now
  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI